How Minor Cannabinoids Like THCV and CBDV Influence the Entourage Effect
Minor cannabinoids clinical relevance is gaining attention as THCV and CBDV appear in more products. Understanding their role in the entourage effect is crucial for clinical guidance. This article reviews current evidence and practical advice for…
Medical Cannabis and Sleep Quality: Patient-Reported Outcomes Explored
Patient-reported outcomes sleep cannabis reveal promising improvements in sleep quality among medical cannabis users. This emerging clinical evidence highlights the potential role of cannabinoids in sleep medicine. Understanding these outcomes can guide…
New Study Explores Cannabis Effects on Memory and Cognition
Cannabis memory cognitive function is a complex area of research with new studies providing fresh insights. This study examines how acute cannabis use affects memory and cognition. Understanding these effects is crucial for clinical relevance and patient…
Clinics Handing Out Medicinal Cannabis for Anxiety and Depression Despite ‘No Evidence’ It Works
Clinics handing out medicinal cannabis anxiety treatments are increasing despite limited evidence of effectiveness. This trend raises important questions for clinicians and patients alike. Monitoring emerging research is essential for informed clinical…
Cannabis Regulation in Sports – The Cureus Journal of Medical Science
This article covers cannabis regulation sports developments with clinical relevance. It highlights important evidence and policy updates from the Cureus Journal of Medical Science. Clinicians and sports professionals should review this focus area…
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin
The cannabinoids chronic pain evidence review reveals moderate efficacy signals across several conditions but highlights the low quality of current studies. While cannabinoids show promise, the evidence remains thin due to small sample sizes and short…
Medical Cannabis for Chronic Pain: Promise, Pharmacology, and Persistent Gaps
This 2025 medical cannabis chronic pain review examines the pharmacology and clinical evidence for cannabinoids in pain management. While promising, significant gaps remain in standardized dosing and long-term safety data. The review highlights the need…
FloraWorks Announces TruCBN(TM) Readiness for CMS Substance Access Program
FloraWorks has announced TruCBN(TM) readiness for CMS Substance Access, highlighting CBN clinical validation pathways. This development signals potential regulatory progress for cannabinoid products. Clinicians should monitor emerging evidence on CBN…
CBD for Calm: How to Use It in Real Life (Timing, Format & What to Expect)
CBD dosing anxiety treatment is a common patient inquiry in cannabis medicine. Clear, evidence-based guidance helps clinicians counsel patients effectively. Understanding dosing protocols and realistic expectations is key to using CBD for calm.
Cell-by-Cell Analysis Offers Clues to Pregnancy Risks – EurekAlert!
Pregnancy risks cell-by-cell analysis offers new insights into potential complications during pregnancy. This emerging research highlights the importance of cellular-level study for clinical relevance. Understanding these risks can improve monitoring and…